Image File (Img0001)
Nuwiq Kit
Product Images NDC 68982-151
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Nuwiq (NDC 68982-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image File (Img0002)
Image File (Img0003)
Image Description (Img0004)
NUWIQ is a type of antihemophilic factor (Recombinant) used for intravenous injection. It comes in a lyophilized powder form which should be dissolved in the supplied solvent before injection. NUWIQ is solvent/detergent treated and nanofiltered, and does not contain preservatives. It should not be frozen. The package is made in Sweden and the product is sold with a prescription.*
Image Description (Img0005)
NUWIQ® is an Antihemophilic Factor (Recombinant) medication used for the treatment of hemophilia A. It is available in 250 IU range and should be stored at a temperature between 0°C-25°C. The medication should not be used after the expiration date printed on the package and should be used within 3 hours after reconstitution. Dosage percentage should be determined by a healthcare professional.*
Image Description (Img0006)
NUWIQ® 500 IU Range is a medication used for intravenous injection only to treat hemophilia A. The medication is composed of Solvent/Detergent Treated, Nanofiltered Antihemophilic Factor (Recombinant) and is supplied in lyophilized powder form. Prior to injection, reconstitution with the supplied solvent from 9ctapharma® is necessary. NUWIQ 5001U should not be frozen and comes without preservatives. The medication is produced by Octapharma, a Swedish company with license number 1646 in the US.*
Image Description (Img0007)
Image Description (Img0008)
Antihemophilic Factor (Recombinant) is a lyophilized powder that is solvent/detergent treated, nanofiltered for intravenous injection. The product is supplied with a solvent that is to be used for reconstitution of the powder. NUWIQ 10001U is not meant to be frozen and is only available on prescription in Sweden. License No. 1646.*
Image Description (Img0009)
Antihemophilic Factor (Recombinant) is a medication that helps in preventing bleeding or bruising in people with hemophilia. The medication is available in a single dosage package that contains one vial of lyophilized powder that must be reconstituted before use. The product contains recombinant proteins and should be stored at a temperature between 2-8°C until use. The package insert also provides instructions for the proper storage and handling of the medication.*
Image Description (Img0010)
NUWIQ 150 is an antihemophilic factor that is used for intravenous injection. It is a lyophilized powder that should not be frozen and is reconstituted with Octapharma's supplied solvent. NUWIQ 150 is solvent/detergent treated and nanofiltered, making it suitable for intravenous injection only, and should only be used under prescription.*
Image Description (Img0011)
Not available.*
Image Description (Img0012)
NUWIQ® is an antihemophilic factor (Recombinant) used for intravenous injection after reconstitution with solvent, supplied by Octapharma®. It is a lyophilized powder that has been solvent/detergent treated and nanofiltered. The drug does not contain preservatives and should not be frozen. Its NDC number is 6896214601, and it is approved for use only by prescription. Additional information such as dosage or administration should be obtained from a medical professional.*
Image Description (Img0013)
Image Description (Img0014)
NUWIQ is a lyophilized powder that is used for intravenous injection. It is an Antihemophilic Factor that has been Solvent/Detergent Treated and Nanofiltered to ensure safety and efficacy. NUWIQ is reconstituted with an octaphama® supplied solvent and has no preservatives. The product should not be frozen and is available only by prescription. This product is manufactured by Octaphama.*
Image Description (Img0015)
This is not-available as the text seems to be a random assortment of characters and words without any coherence or context.*
Image Description (Img0016)
Image Description (Img0017)
Image Description (Img0018)
NUWIQ® is an antihemophilic factor (recombinant) used for intravenous injection only. It is a lyophilized powder that must be reconstituted with Octaplas® supplied solvent, without preservatives. NUWIQ® is solvent/detergent treated, nano-filtered to ensure its safety for individuals with hemophilia. It should not be frozen due to its sensitivity. NUWIQ® is manufactured in Sweden and has a US License number of 1646.*
Img0019
Not available.*
Img0020
This is a description of a vial of medication that requires reconstitution. The medication is named NUwIQ and the vial contains 2.5 mL of Water for Injection. It is important to note that there is no preservative and the medication should be stored at a temperature of 2°C to 8°C within the indicated expiry date. The medication should not be frozen. The manufacturer of this medication is Octapharma and it is distributed by Octapharma USA. The product has a lot number and an expiration date indicated as OWXX99XX MM/YYYY.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
